Psychedelic tourism is growing fast, and so is the number of people booking retreats abroad with little more than a website and a payment link between them and a high-dose experience. Psychedelic retreat abroad safety depends heavily on who is running the program,...
Ibogaine opioid treatment research has moved significantly forward in 2025 and 2026, with new clinical data, a landmark $50 million Texas state investment, and a federal executive order directing agencies to accelerate review. The evidence shows real potential for...
RFK Jr. psychedelic therapy support has brought real political attention to substances like psilocybin, MDMA, and ibogaine. For seekers already exploring this space, the shift matters. It does not, however, change what responsible engagement looks like at the...
Texas has committed $50 million to fund clinical trials for ibogaine treatment Texas programs focused on veterans and first responders. The research is early and the risks are real, but the implications for PTSD, addiction, and traumatic brain injury are significant...
